Health-related quality of life across the anxiety disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)

Journal of Clinical Psychiatry

Volumn 72, Issue 1, 2011, Pages 43-50

  Comer, Jonathan S ^a   Blanco, Carlos ^a   Hasin, Deborah S ^b   Liu, Shang Min ^a   Grant, Bridget F ^c   Turner, J Blake ^a   Olfson, Mark ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b Mailman School of Public Health ^*  (United States)

^c NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANXIETY DISORDER; ARTICLE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; INCOME; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PANIC; PHOBIA; PHYSICAL DISEASE; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; SOCIAL INTERACTION; SOCIAL PHOBIA; UNITED STATES;

ADOLESCENT; ADULT; ALCOHOLISM; ANXIETY DISORDERS; DATA COLLECTION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HEALTH STATUS; HEALTH SURVEYS; HUMANS; MALE; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; QUESTIONNAIRES; UNITED STATES;

EID: 79551529505     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.09m05094blu     Document Type: Article

References (78)

1. Kessler RC, Chiu WT, Demler O, et al. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):617-627. doi:10.101/archpsyc.62.6. 617 (Pubitemid 40973437)
2. Greenberg PE, Sisitsky T, Kessler RC, et al. The economic burden of anxiety disorders in the 1990s. J Clin Psychiatry. 1999;60(7):427-435. (Pubitemid 29369796)
3. Kessler RC, Greenberg PE. The economic burden of anxiety and stress disorders. In: Davis K, ed. Neuropsychopharmacology: The Fifth Generation of Progress. Baltimore, MD: The American College of Neuropsychopharmacology and Lippincott Williams & Wilkins; 2002.
4. Rice DP, Miller LS. Health economics and cost implications of anxiety and other mental disorders in the United States. Br J Psychiatry Suppl. 1998;34:4-9. (Pubitemid 28312191)
5. Wittchen H-U. Generalized anxiety disorder: prevalence, burden, and cost to society. Depress Anxiety. 2002;16(4):162-171. doi:10.102/da.1065 (Pubitemid 36015426)
6. Kessler RC, Frank RG. The impact of psychiatric disorders on work loss days. Psychol Med. 1997;27(4):861-873. doi:10.1017/S0329179704807 (Pubitemid 27332173)
7. Zaubler TS, Katon W. Panic disorder and medical comorbidity: a review of the medical and psychiatric literature. Bull Menninger Clin. 1996;60(suppl A):A12-A38. (Pubitemid 26158291)
8. Brady EU, Kendall PC. Comorbidity of anxiety and depression in children and adolescents. Psychol Bull. 1992;111(2):244-255. doi:10.1037/03-2909.1.2.24
9. Compton WM, Thomas YF, Stinson FS, et al. Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry. 2007;64(5):566-576. doi:10.101/archpsyc.64.5.56 (Pubitemid 46718289)
10. Conway KP, Compton W, Stinson FS, et al. Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2006;67(2):247-258. doi:10.408/JCP.v67n021
11. Grant BF, Hasin DS, Blanco C, et al. The epidemiology of social anxiety disorder in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2005;66(11):1351-1361. doi:10.408/JCP.v6n102 (Pubitemid 41779531)
12. Grant BF, Hasin DS, Stinson FS, et al. Prevalence, correlates, co-morbidity, and comparative disability of DSM-IV generalized anxiety disorder in the USA: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Psychol Med. 2005;35(12):1747-1759. doi:10.1017/ S0329170506069 (Pubitemid 41672353)
13. Kessler RC, Stang PE, Wittchen H-U, et al. Lifetime panic-depression comorbidity in the National Comorbidity Survey. Arch Gen Psychiatry. 1998;55(9):801-808. doi:10.101/archpsyc.5.9.801 (Pubitemid 28413042)
14. Kessler RC, Borges G, Walters EE. Prevalence of and risk factors for lifetime suicide attempts in the National Comorbidity Survey. Arch Gen Psychiatry. 1999;56(7):617-626. doi:10.101/archpsyc.56.7.617 (Pubitemid 29315633)
15. Pilowsky DJ, Olfson M, Gameroff MJ, et al. Panic disorder and suicidal ideation in primary care. Depress Anxiety. 2006;23(1):11-16. doi:10.102/da.2092
16. Weissman MM, Klerman GL, Markowitz JS, et al. Suicidal ideation and suicide attempts in panic disorder and attacks. N Engl J Med. 1989;321(18):1209-1214. (Pubitemid 19273029)
17. Mendlowicz MV, Stein MB. Quality of life in individuals with anxiety disorders. Am J Psychiatry. 2000;157(5):669-682. doi:10.176/api.ajp.157.5.69 (Pubitemid 30249642)
18. Wang PS, Berglund P, Olfson M, et al. Failure and delay in initial treatment contact after first onset of mental disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):603-613. doi:10.101/archpsyc.62.6.603 (Pubitemid 40973435)
19. Kessler RC, Zhao S, Katz SJ, et al. Past-year use of outpatient services for psychiatric problems in the National Comorbidity Survey. Am J Psychiatry. 1999;156(1):115-123. (Pubitemid 29034888)
20. Ware JE, Kosinski M, Keller SK. SF-36 Physical and Mental Health Summary Scales: A User's Manual. Boston, MA: The Health Institute; 1994.
21. Ware JE, Kosinski M, Keller SK. How to Score the SF-12 Physical and Mental Health Summary Scales. 2nd ed. Boston, MA: The Health Institute, New England Medical Center; 1995.
22. Turner-Bowker DM, Bartley PJ, Ware JE. SF-36 Health Survey & SF Bibliography. 3rd ed. Lincoln, RI: QualityMetric Inc; 2002:1988-2000.
23. Dorr DA, Jones SS, Burns L, et al. Use of health-related, quality-of-life metrics to predict mortality and hospitalizations in community-dwelling seniors. J Am Geriatr Soc. 2006;54(4):667-673. doi:10.1/j.1532-5415.206.0681.x
24. Earlam S, Glover C, Fordy C, et al. Relation between tumor size, quality of life, and survival in patients with colorectal liver metastases. J Clin Oncol. 1996;14(1):171-175. (Pubitemid 26020010)
25. Mainio A, Tuunanen S, Hakko H, et al. Decreased quality of life and depression as predictors for shorter survival among patients with low-grade gliomas: a follow-up from 1990 to 2003. Eur Arch Psychiatry Clin Neurosci. 2006;256(8):516-521. doi:10.107/s0406-06-0674-2
26. Jones GN, Ames SC, Jeffries SK, et al. Utilization of medical services and quality of life among low-income patients with generalized anxiety disorder attending primary care clinics. Int J Psychiatry Med. 2001;31(2):183-198. doi:10.2190/2X4-CR14-YHJC-9EQ3 (Pubitemid 33049662)
27. Olfson M, Fireman B, Weissman MM, et al. Mental disorders and disability among patients in a primary care group practice. Am J Psychiatry. 1997;154(12):1734-1740. (Pubitemid 27516592)
28. Ormel J, VonKorff M, Ustun TB, et al. Common mental disorders and disability across cultures: results from the WHO Collaborative Study on Psychological Problems in General Health Care. JAMA. 1994;272(22):1741-1748. doi:10.101/jama.272.2.1741 (Pubitemid 24372001)
29. Stein MB, Roy-Byrne PP, Craske MG, et al. Functional impact and health utility of anxiety disorders in primary care outpatients. Med Care. 2005;43(12):1164-1170. doi:10.1097/01.mlr.0185750.1819.fd (Pubitemid 43012172)
30. Antony MM, Roth D, Swinson RP, et al. Illness intrusiveness in individuals with panic disorder, obsessive-compulsive disorder, or social phobia. J Nerv Ment Dis. 1998;186(5):311-315. doi:10.1097/05053-198050-08 (Pubitemid 28232965)
31. Eng W, Coles ME, Heimberg RG, et al. Domains of life satisfaction in social anxiety disorder: relation to symptoms and response to cognitivebehavioral therapy. J Anxiety Disord. 2005;19(2):143-156. doi:10.1016/j.janxdis.204.01.07 (Pubitemid 39469089)
32. Hambrick JP, Turk CL, Heimberg RG, et al. The experience of disability and quality of life in social anxiety disorder. Depress Anxiety. 2003;18(1):46-50. doi:10.102/da.1010 (Pubitemid 37012935)
33. Massion AO, Warshaw MG, Keller MB. Quality of life and psychiatric morbidity in panic disorder and generalized anxiety disorder. Am J Psychiatry. 1993;150(4):600-607. (Pubitemid 23109929)
34. Norton GR, McLeod L, Guertin J, et al. Panic disorder or social phobia: which is worse? Behav Res Ther. 1996;34(3):273-276. doi:10.1016/05-7967(95)06-6
35. Rodriguez BF, Bruce SE, Pagano ME, et al. Relationships among psychosocial functioning, diagnostic comorbidity, and the recurrence of generalized anxiety disorder, panic disorder, and major depression. J Anxiety Disord. 2005;19(7):752-766. doi:10.1016/j.janxdis.204.10.02 (Pubitemid 41074946)
36. Sanderson K, Andrews G. Prevalence and severity of mental health-related disability and relationship to diagnosis. Psychiatr Serv. 2002;53(1):80-86. doi:10.176/api.ps.53.1.80 (Pubitemid 34038620)
37. Grant BF, Hasin DS, Stinson FS, et al. The epidemiology of DSM-IV panic disorder and agoraphobia in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2006;67(3):363-374. doi:10.408/JCP.v67n0305
38. Henning ER, Turk CL, Mennin DS, et al. Impairment and quality of life in individuals with generalized anxiety disorder. Depress Anxiety. 2007;24(5):342-349. doi:10.102/da.20249 (Pubitemid 47403484)
39. Kessler RC, DuPont RL, Berglund P, et al. Impairment in pure and comorbid generalized anxiety disorder and major depression at 12 months in two national surveys. Am J Psychiatry. 1999;156(12):1915-1923.
40. Kessler RC, Stein MB, Berglund P. Social phobia subtypes in the National Comorbidity Survey. Am J Psychiatry. 1998;155(5):613-619. (Pubitemid 28225400)
41. Markowitz JS, Weissman MM, Ouellette R, et al. Quality of life in panic disorder. Arch Gen Psychiatry. 1989;46(11):984-992.
42. Stein MB, Kean YM. Disability and quality of life in social phobia: epidemiologic findings. Am J Psychiatry. 2000;157(10):1606-1613. doi:10.176/api.ajp.157.10.1606
43. Stein MB, Heimberg RG. Well-being and life satisfaction in generalized anxiety disorder: comparison to major depressive disorder in a community sample. J Affect Disord. 2004;79(1-3):161-166. doi:10.1016/S0165-0327(02)0457-3 (Pubitemid 38340539)
44. Saarni SI, Suvisaari J, Sintonen H, et al. Impact of psychiatric disorders on health-related quality of life: general population survey. Br J Psychiatry. 2007;190(4):326-332. doi:10.192/bjp.bp.106.025106 (Pubitemid 46580682)
45. Grant BF, Kaplan K, Shepard J, et al. Source and Accuracy Statement for Wave 1 of the 2001-2002 National Epidemiologic Survey on Alcohol and Related Conditions. Bethesda, MD: National Institute on Alcohol Abuse and Alcoholism; 2003.
46. Grant BF, Stinson FS, Dawson DA, et al. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2004;61(8):807-816. doi:10.101/archpsyc.61.8.807 (Pubitemid 39031120)
47. Grant BF, Dawson DA. The Alcohol Use Disorder and Associated Disabilities Interview Schedule-IV (AUDADIS-IV). Rockville, MD: National Institute on Alcohol Abuse and Alcoholism; 2000.
48. Grant BF, Dawson DA, Stinson FS, et al. The Alcohol Use Disorder and Associated Disabilities Interview Schedule-IV (AUDADIS-IV): reliability of alcohol consumption, tobacco use, family history of depression and psychiatric diagnostic modules in a general population sample. Drug Alcohol Depend. 2003;71(1):7-16. doi:10.1016/S0376-8716(03)070-X (Pubitemid 36734856)
49. Wittchen H-U. Reliability and validity studies of the WHO-Composite International Diagnostic Interview (CIDI): a critical review. J Psychiatr Res. 1994;28(1):57-84. doi:10.1016/02-3956(94)9036-1
50. Wittchen H-U, Kessler RC, Zhao S, et al. Reliability and clinical validity of UM-CIDI DSM-III-R generalized anxiety disorder. J Psychiatr Res. 1995;29(2):95-110. doi:10.1016/02-3956(94)04-R
51. Wittchen H-U, Zhao S, Abelson JM, et al. Reliability and procedural validity of UM-CIDI DSM-III-R phobic disorders. Psychol Med. 1996;26(6):1169-1177. doi:10.1017/S032917035893 (Pubitemid 26382011)
52. Grant BF, Hasin DS, Stinson FS, et al. Prevalence, correlates, and disability of personality disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. J Clin Psychiatry. 2004;65(7):948-958. doi:10.408/JCP.v65n071
53. Ware JE, Kosinski M, Turner-Bowker DM, et al. How to Score Version 2 of the SF-12 Health Survey. Lincoln, RI: QualityMetric; 2005.
54. Manocchia M, Bayliss MS, Connor J, et al. SF-36 Health Survey Annotated Bibliography. 2nd ed. Boston, MA: The Health Assessment Lab; 1998:1988-1996.
55. Ware JE Jr, Gandek B. Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project. J Clin Epidemiol. 1998;51(11):903-912. doi:10.1016/S0895-4356(98)081-X (Pubitemid 28527145)
56. Ware JE, Snow KK, Kosinski M, et al. SF-36 Health Survey Manual and Interpretation Guide. The Health Institute. Boston, MA: The Health Assessment Lab; 1993.
57. Research Triangle Institute. Software for Survey Data Analyses (Version 9.01). Research Triangle Park, NC: RTI; 2004.
58. Dugas MJ, Robichaud M. Cognitive-Behavioral Treatment for Generalized Anxiety Disorder: From Science to Practice. New York, NY: Routledge; 2006.
59. Safren SA, Heimberg RG, Brown EJ, et al. Quality of life in social phobia. Depress Anxiety. 1996-1997;4(3):126-133. doi:10.102/(SICI)1520-6394(196) 4:3〈126:AID-DA5〉3.0.CO;2-E
60. Schneier FR, Heckelman LR, Garfinkel R, et al. Functional impairment in social phobia. J Clin Psychiatry. 1994;55(8):322-331.
61. Wittchen H-U, Fuetsch M, Sonntag H, et al. Disability and quality of life in pure and comorbid social phobia. Findings from a controlled study. Eur Psychiatry. 2000;15(1):46-58. doi:10.1016/S0924-938(0)021-X
62. Holt CS, Heimberg RG, Hope DA. Avoidant personality disorder and the generalized subtype of social phobia. J Abnorm Psychol. 1992;101(2):318-325. doi:10.1037/021-843X.101.2.318
63. Hummelen B, Wilberg T, Pedersen G, et al. The relationship between avoidant personality disorder and social phobia. Compr Psychiatry. 2007;48(4):348-356. doi:10.1016/j.compsych.207.03.04 (Pubitemid 46874369)
64. Candilis PJ, McLean RY, Otto MW, et al. Quality of life in patients with panic disorder. J Nerv Ment Dis. 1999;187(7):429-434. doi:10.1097/05053-19070-06 (Pubitemid 29342958)
65. Ettigi P, Meyerhoff AS, Chirban JT, et al. The quality of life and employment in panic disorder. J Nerv Ment Dis. 1997;185(6):368-372. doi:10.1097/05053-197060-02 (Pubitemid 27293521)
66. Hollifield M, Katon W, Skipper B, et al. Panic disorder and quality of life: variables predictive of functional impairment. Am J Psychiatry. 1997;154(6):766-772. (Pubitemid 27230098)
67. Sherbourne CD, Wells KB, Judd LL. Functioning and well-being of patients with panic disorder. Am J Psychiatry. 1996;153(2):213-218. (Pubitemid 26038962)
68. Craske MG, Sanderson WC, Barlow DH. The relationships among panic, fear, and avoidance. J Anx Dis. 1987;1(2):153-160. doi:10.1016/087-6185(87)905-3
69. White KS, Brown TA, Somers TJ, et al. Avoidance behavior in panic disorder: the moderating influence of perceived control. Behav Res Ther. 2006;44(1):147-157. doi:10.1016/j.brat.205.07.09 (Pubitemid 41654487)
70. MacKinnon DP, Krull JL, Lockwood CM. Equivalence of the mediation, confounding and suppression effect. Prev Sci. 2000;1(4):173-181. doi:10.1023/A:102659501371
71. Goodwin RD, Stein MB. Generalized anxiety disorder and peptic ulcer disease among adults in the United States. Psychosom Med. 2002;64(6):862-866. doi:10.1097/01.PSY.038935.67401.F3 (Pubitemid 35417128)
72. Kessler RC, Berglund P, Demler O, et al. Lifetime prevalence and age-ofonset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):593-602. doi:10.101/archpsyc.62.6. 593 (Pubitemid 40973434)
73. ESEMeD/MHEDEA 2000 Investigators. Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand. 2004;109(suppl 420):21-27. doi:10.1/j.160-047.204.0327.x
74. McHugh RK, Otto MW, Barlow DH, et al. Cost-efficacy of individual and combined treatments for panic disorder. J Clin Psychiatry. 2007;68(7):1038-1044. doi:10.408/JCP.v68n0710 (Pubitemid 47340324)
75. Barlow DH. Anxiety and Its Disorders (2nd Ed): The Nature and Treatment of Anxiety and Panic. New York, NY: Guilford Press; 2004.
76. Heimberg RG, Turk CL, Mennin DS. Generalized Anxiety Disorder: Advances in Research and Practice. New York, NY: Guilford Press; 2004.
77. Rickels K, Zaninelli R, McCafferty J, et al. Paroxetine treatment of generalized anxiety disorder: a double-blind, placebo-controlled study. Am J Psychiatry. 2003;160(4):749-756. doi:10.176/api.ajp.160.4.749 (Pubitemid 41079609)
78. Stein MB, Liebowitz MR, Lydiard RB, et al. Paroxetine treatment of generalized social phobia (social anxiety disorder): a randomized controlled trial. JAMA. 1998;280(8):708-713. (Pubitemid 28405295)